ALTH

ALLOS THERAPEUTICS INCCIK 1097264 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ALTH PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ALTH

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
SAPPHIRE ACQUISITION SUB, INC.	10% Owner	1	$238.16M	$0	2012-09-05
Warburg Pincus Private Equity VIII, L.P.	Director, 10% Owner	1	$0	$0	2012-09-05
Schick Michael E	VP, Sales and Marketing	6	$0	$15.6K	2012-09-04
Goldsmith Bruce A	SVP, Corporate Development	6	$0	$18.4K	2012-09-04
Morris Charles Q	Chief Medical Officer	8	$0	$75.0K	2012-09-04
GONZALO CECILIA	Director	1	$0	$0	2012-09-04
Graboyes Marc H	SVP, General Counsel	6	$0	$37.0K	2012-09-04
Clark David C	VP, Finance	6	$0	$13.4K	2012-09-04
TURNER JOSEPH L	Director	1	$0	$0	2012-09-04
STOUT DAVID M	Director	1	$0	$0	2012-09-04
BENNETT BRUCE K JR	VP, Pharmaceutical Operations	8	$2.8K	$18.5K	2012-09-04
LEFF JONATHAN S	Director	1	$0	$0	2012-09-04
BERNS PAUL L	Chief Executive Officer	6	$0	$85.0K	2012-09-04
LATTS JEFFREY	Director	1	$0	$0	2012-09-04
HOFFMAN STEPHEN J	Director	7	$0	$0	2012-09-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Warburg Pincus Private Equity	Director, 10% Owner	U Tender	2012-09-05	2012-09-06	26,124,430	$1.82	$47.55M	0	SEC↗
SAPPHIRE ACQUISITION SUB, INC.	10% Owner	P Buy	2012-09-05	2012-09-06	130,854,840	$1.82	$238.16M	1,000	SEC↗
GONZALO CECILIA	Director	U Tender deriv	2012-09-04	2012-09-05	25,000	$1.82	$45.5K	0	SEC↗
BERNS PAUL L	Chief Executive Officer	U Tender	2012-09-04	2012-09-05	1,233,323	$1.82	$2.24M	0	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	U Tender	2012-09-04	2012-09-05	148,482	$1.82	$270.2K	0	SEC↗
Clark David C	VP, Finance	U Tender	2012-09-04	2012-09-05	207,114	$1.82	$376.9K	0	SEC↗
Graboyes Marc H	SVP, General Counsel	U Tender	2012-09-04	2012-09-05	542,028	$1.82	$986.5K	0	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	U Tender	2012-09-04	2012-09-05	346,933	$1.82	$631.4K	0	SEC↗
Morris Charles Q	Chief Medical Officer	U Tender	2012-09-04	2012-09-05	655,031	$1.82	$1.19M	0	SEC↗
Schick Michael E	VP, Sales and Marketing	U Tender	2012-09-04	2012-09-05	285,113	$1.82	$518.9K	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	472,871	$1.82	$860.6K	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	92,000	$1.82	$167.4K	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	200	$1.82	$364	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	200	$1.82	$364	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	200	$1.82	$364	0	SEC↗
HOFFMAN STEPHEN J	Director	U Tender	2012-09-04	2012-09-05	200	$1.82	$364	0	SEC↗
LATTS JEFFREY	Director	U Tender	2012-09-04	2012-09-05	55,000	$1.82	$100.1K	0	SEC↗
LEFF JONATHAN S	Director	U Tender	2012-09-04	2012-09-05	55,000	$1.82	$100.1K	0	SEC↗
STOUT DAVID M	Director	U Tender	2012-09-04	2012-09-05	35,000	$1.82	$63.7K	0	SEC↗
TURNER JOSEPH L	Director	U Tender	2012-09-04	2012-09-05	55,000	$1.82	$100.1K	0	SEC↗
Schick Michael E	VP, Sales and Marketing	S Sale	2012-07-11	2012-07-13	697	$1.78	$1.2K	285,113	SEC↗
Morris Charles Q	Chief Medical Officer	S Sale	2012-04-27	2012-04-30	7,970	$1.81	$14.4K	665,323	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	P Buy	2012-04-27	2012-04-30	1,104	$1.22	$1.3K	148,482	SEC↗
Morris Charles Q	Chief Medical Officer	S Sale	2012-04-27	2012-05-22	7,970	$1.81	$14.4K	655,031	SEC↗
Morris Charles Q	Chief Medical Officer	S Sale	2012-03-01	2012-05-22	10,292	$1.48	$15.2K	663,001	SEC↗
Schick Michael E	VP, Sales and Marketing	S Sale	2012-03-01	2012-03-01	3,960	$1.48	$5.9K	285,810	SEC↗
Graboyes Marc H	SVP, General Counsel	S Sale	2012-03-01	2012-03-01	9,635	$1.48	$14.3K	542,028	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	S Sale	2012-03-01	2012-03-01	4,473	$1.50	$6.7K	346,933	SEC↗
Clark David C	VP, Finance	S Sale	2012-03-01	2012-03-01	3,385	$1.50	$5.1K	207,114	SEC↗
BERNS PAUL L	Chief Executive Officer	S Sale	2012-03-01	2012-03-01	21,532	$1.48	$31.9K	1,233,323	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	S Sale	2012-03-01	2012-03-01	3,025	$1.50	$4.5K	147,378	SEC↗
Morris Charles Q	Chief Medical Officer	S Sale	2012-02-29	2012-05-22	10,155	$1.52	$15.4K	673,293	SEC↗
Schick Michael E	VP, Sales and Marketing	S Sale	2012-02-29	2012-03-01	3,894	$1.52	$5.9K	289,770	SEC↗
Morris Charles Q	Chief Medical Officer	S Sale	2012-02-29	2012-03-01	10,155	$1.52	$15.4K	673,293	SEC↗
Graboyes Marc H	SVP, General Counsel	S Sale	2012-02-29	2012-03-01	9,425	$1.52	$14.3K	551,663	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	S Sale	2012-02-29	2012-03-01	4,505	$1.52	$6.8K	351,406	SEC↗
Clark David C	VP, Finance	S Sale	2012-02-29	2012-03-01	3,388	$1.52	$5.1K	210,499	SEC↗
BERNS PAUL L	Chief Executive Officer	S Sale	2012-02-29	2012-03-01	21,163	$1.52	$32.2K	1,254,855	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	S Sale	2012-02-29	2012-03-01	3,031	$1.53	$4.6K	150,403	SEC↗
Morris Charles Q	Chief Medical Officer	A Award	2012-02-28	2012-05-22	241,848	—	$0	683,448	SEC↗
Schick Michael E	VP, Sales and Marketing	A Award	2012-02-28	2012-03-01	135,545	—	$0	293,664	SEC↗
Morris Charles Q	Chief Medical Officer	A Award	2012-02-28	2012-03-01	241,848	—	$0	683,448	SEC↗
Graboyes Marc H	SVP, General Counsel	A Award	2012-02-28	2012-03-01	222,266	—	$0	561,088	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	A Award	2012-02-28	2012-03-01	179,727	—	$0	355,911	SEC↗
Clark David C	VP, Finance	A Award	2012-02-28	2012-03-01	99,779	—	$0	213,887	SEC↗
BERNS PAUL L	Chief Executive Officer	A Award	2012-02-28	2012-03-01	573,506	—	$0	1,276,018	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	A Award	2012-02-28	2012-03-01	43,862	—	$0	153,434	SEC↗
Graboyes Marc H	SVP, General Counsel	S Sale	2012-02-24	2012-02-27	1,380	$1.54	$2.1K	338,822	SEC↗
Clark David C	VP, Finance	S Sale	2012-02-24	2012-02-27	595	$1.55	$922	114,108	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	S Sale	2012-02-24	2012-02-27	575	$1.54	$886	176,184	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	S Sale	2012-02-24	2012-02-27	1,469	$1.55	$2.3K	109,572	SEC↗
BERNS PAUL L	Chief Executive Officer	S Sale	2012-02-24	2012-02-27	4,350	$1.55	$6.7K	702,512	SEC↗
Graboyes Marc H	SVP, General Counsel	S Sale	2012-02-23	2012-02-27	3,950	$1.58	$6.2K	340,202	SEC↗
Schick Michael E	VP, Sales and Marketing	S Sale	2012-02-23	2012-02-27	1,645	$1.58	$2.6K	158,119	SEC↗
Clark David C	VP, Finance	S Sale	2012-02-23	2012-02-27	1,460	$1.57	$2.3K	114,703	SEC↗
Goldsmith Bruce A	SVP, Corporate Development	S Sale	2012-02-23	2012-02-27	2,500	$1.58	$4.0K	176,759	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	S Sale	2012-02-23	2012-02-27	4,484	$1.58	$7.1K	111,041	SEC↗
BERNS PAUL L	Chief Executive Officer	S Sale	2012-02-23	2012-02-27	9,100	$1.56	$14.2K	706,862	SEC↗
BENNETT BRUCE K JR	VP, Pharmaceutical Operation	P Buy	2011-12-30	2012-01-03	1,173	$1.21	$1.4K	115,525	SEC↗
HOFFMAN STEPHEN J	Director	A Award	2011-12-13	2012-04-13	90,000	—	$0	92,000	SEC↗